Works matching IS 21641153 AND DT 2019 AND VI 9 AND IP 1
Results: 12
Trump Administration Moves to Curb Drug Rebates in Medicare, Medicaid: Proposal, likely to draw industry resistance, would limit rebates drugmakers give to third parties.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2019, v. 9, n. 1, p. 54
- By:
- Publication type:
- Article
First-Line Ibrutinib Improves Outcomes Compared with Current Standard of Care in Older Patients with CLL.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2019, v. 9, n. 1, p. 51
- By:
- Publication type:
- Article
Durable Responses to CAR T-Cell Therapy in B-Cell Lymphomas.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2019, v. 9, n. 1, p. 49
- Publication type:
- Article
Checkpoint Inhibitor a New Approach to Jump-Start a Waning Response to CAR T-Cell Therapy.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2019, v. 9, n. 1, p. 48
- Publication type:
- Article
Researchers Identify First Mutation to Explain Resistance to Venetoclax.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2019, v. 9, n. 1, p. 47
- Publication type:
- Article
MURANO: Venetoclax-Rituximab at Fixed Duration Beats Chemoimmunotherapy in Relapsed/Refractory CLL.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2019, v. 9, n. 1, p. 46
- By:
- Publication type:
- Article
Checkpoint Inhibition Consolidation Therapy Promising in High-Risk Hematologic Malignancies.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2019, v. 9, n. 1, p. 45
- By:
- Publication type:
- Article
Sterility Duration of Single-Use Vials for Antineoplastic Agents or Monoclonal Antibodies Extended with a Closed-System Transfer Device.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2019, v. 9, n. 1, p. 40
- By:
- Publication type:
- Article
Concise Reviews of Studies Relevant to Hematology Oncology Pharmacy.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2019, v. 9, n. 1, p. 36
- By:
- Publication type:
- Article
Effectiveness of a Single 6-mg Fixed Dose of Rasburicase for Prevention or Management of Hyperuricemia Associated with Tumor Lysis Syndrome in Adults with Cancer.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2019, v. 9, n. 1, p. 30
- By:
- Publication type:
- Article
Reactivation of Myasthenia Gravis Secondary to Nivolumab: Case Report and Literature Review.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2019, v. 9, n. 1, p. 24
- By:
- Publication type:
- Article
Olanzapine for Prevention or Management of Chemotherapy-Induced Nausea and Vomiting: A Promising Option.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2019, v. 9, n. 1, p. 9
- By:
- Publication type:
- Article